Trade Anytime, Anywhere
Important Information
This website is managed by Ultima Markets’ international entities, and it’s important to emphasise that they are not subject to regulation by the FCA in the UK. Therefore, you must understand that you will not have the FCA’s protection when investing through this website – for example:
Note: Ultima Markets is currently developing a dedicated website for UK clients and expects to onboard UK clients under FCA regulations in 2026.
If you would like to proceed and visit this website, you acknowledge and confirm the following:
Ultima Markets wants to make it clear that we are duly licensed and authorised to offer the services and financial derivative products listed on our website. Individuals accessing this website and registering a trading account do so entirely of their own volition and without prior solicitation.
By confirming your decision to proceed with entering the website, you hereby affirm that this decision was solely initiated by you, and no solicitation has been made by any Ultima Markets entity.
I confirm my intention to proceed and enter this website Please direct me to the website operated by Ultima Markets , regulated by the FCA in the United KingdomIntuitive Surgical (ISRG) is a leader in robotic-assisted surgery and has long been a standout performer in the healthcare sector. Known for its da Vinci Surgical System and other cutting-edge products, the company has demonstrated consistent growth, and its stock has surged significantly over the years.
Historically, Intuitive Surgical has executed stock splits when the share price climbs to high levels, making it harder for retail investors to purchase shares. With the current price around $561.80 (as of December 2025), many investors are wondering: Will Intuitive Surgical split its stock soon?

In this article, we will explore the Intuitive Surgical stock split history, how the stock performed before and after previous splits, and whether the company is likely to split its stock again soon.
Intuitive Surgical has executed stock splits on three occasions in its history:
These splits occurred when the stock price rose significantly, particularly over the $1,000 mark. After the 2021 split, the stock price adjusted to around $400, and since then, it has steadily climbed to its current level of around $561.80.
Intuitive Surgical’s stock has shown a pattern of strong growth before and after stock splits. Here’s how the stock has performed in the past:
Leading up to the company’s past stock splits, Intuitive Surgical’s stock price experienced significant appreciation. For example, before the 2017 and 2021 splits, the stock had surged well above $1,000, making it too expensive for many retail investors. This often leads to a stock split, which reduces the per-share price and makes the stock more attractive to smaller investors.
After each stock split, Intuitive Surgical’s stock typically sees short-term volatility, followed by continued strong performance. For instance:
In both cases, the stock split allowed the stock to remain accessible to a broader range of investors, while the company’s long-term growth prospects continued to push the stock price higher.
While Intuitive Surgical’s stock price is currently priced at $561.80, it is still below the $1,000 per share threshold that has historically triggered stock splits. However, there are several key factors that suggest a stock split could be on the horizon in the near future:

Intuitive Surgical’s stock price has generally trended higher through 2025, trading near multi‑year highs. Although it has not yet reached the $1,000 mark, the stock’s upward trajectory suggests that another split could happen soon if the price continues to rise. If the stock surpasses the $1,000 level, it is likely that Intuitive Surgical will execute another split to keep the stock affordable and attract more investors.
The company continues to experience robust growth driven by product innovations and expanding market adoption. For example:
This ongoing innovation and double-digit growth in key metrics suggest that the company’s stock could continue its rise, potentially hitting or surpassing the $1,000 level, which would trigger a stock split.
Stocks priced above $1,000 often hit a psychological barrier for many investors. Even though fractional shares are available, not all brokers offer them, and many investors still perceive stocks priced at such high levels as “expensive.”
To maintain broader market participation, Intuitive Surgical may opt to execute a stock split once the price nears or exceeds $1,000, a price point that has historically been a trigger for splits.
Given Intuitive Surgical’s stock price in early 2025 and the strong growth drivers, investors may want to consider adding Intuitive Surgical to their portfolio now, before the potential for a stock split occurs.
Although the stock has not yet hit the $1,000 mark, its consistent growth, innovations, and strong market position suggest that it could reach that level in the near future, making a stock split more likely.
If you’re concerned about the price being too high, it might be worthwhile to keep an eye on the stock’s performance. If the price continues to rise, a stock split could soon follow, making the stock more accessible to a broader group of investors.
While Intuitive Surgical has not announced a stock split as of December 2025, the strong price momentum and consistent growth in key areas make it likely that a stock split could happen if the price moves closer to or surpasses the $1,000 per share mark.

The company has a history of splitting its stock after significant price increases, and with strong earnings, product launches, and market growth, it seems poised for another split in the near future.
Investors should keep an eye on the stock price, as Intuitive Surgical’s continued success could push the stock price high enough to trigger another stock split, making it more accessible to new investors. Whether or not the stock splits, the company’s long-term growth prospects make it a compelling investment opportunity.
Disclaimer: This content is provided for informational purposes only and does not constitute, and should not be construed as, financial, investment, or other professional advice. No statement or opinion contained here in should be considered a recommendation by Ultima Markets or the author regarding any specific investment product, strategy, or transaction. Readers are advised not to rely solely on this material when making investment decisions and should seek independent advice where appropriate.